CMMB Chemomab Therapeutics

Chemomab Therapeutics earnings company data as of 4:45 AM ET 9/7

History

2 periods · newest first · EPS & Rev stacked

Period	Date	Metric	Estimate	Actual	Result
FY2026 Q3	10 Sep	EPS	—	—	—
FY2026 Q3	10 Sep	Rev	—	—	—
FY2026 Q2	20 Aug	EPS	0.00	0.00	—
FY2026 Q2	20 Aug	Rev	—	—	—

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed	Form	Links
Aug 19, 2026	6-K	Filing Doc
Jul 8, 2026	6-K	Filing Doc
Jun 2, 2026	6-K	Filing Doc
May 14, 2026	6-K	Filing Doc
May 6, 2026	6-K	Filing Doc
Apr 28, 2026	6-K	Filing Doc
Mar 23, 2026	20-F	Filing Doc
Mar 20, 2026	6-K	Filing Doc
Mar 19, 2026	6-K	Filing Doc
Nov 21, 2025	6-K	Filing Doc
Aug 22, 2025	6-K	Filing Doc
Aug 14, 2025	6-K	Filing Doc
Jul 25, 2025	424B5	Filing Doc
Jul 25, 2025	6-K	Filing Doc
Jul 1, 2025	6-K	Filing Doc
May 27, 2025	6-K	Filing Doc
May 15, 2025	6-K	Filing Doc
Apr 15, 2025	6-K	Filing Doc
Apr 4, 2025	20-F	Filing Doc
Mar 27, 2025	6-K	Filing Doc
Mar 20, 2025	6-K	Filing Doc
Mar 3, 2025	6-K	Filing Doc
Feb 19, 2025	6-K	Filing Doc
Nov 18, 2024	6-K	Filing Doc
Nov 15, 2024	424B5	Filing Doc

Form 3 / 4 / 5 from EDGAR · 2 rows shown

Filed	Form	Detail	Links
Sep 1, 2026	4	Period Aug 27, 2026	Filing Doc
Jun 1, 2026	4	Period May 29, 2026	Filing Doc

Updated 6 days ago Source: SEC EDGAR submissions All on EDGAR

Consensus estimates · SEC filings remain the official record · not investment advice